Company: TVRD
Filing Date: 2025-02-14
Form Type: S-4/A
Source: 0001104659-25-013053
Chunk: 737

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: S-4/A
Chunk 737
---
sof Cash Flows for the Years EndedDecember 31, 2023 and 2022                                                       | ​ | ​ | ​    | ​ | F-94 | ​ | ​ |
| Notes toFinancial Statements                                                                                                | ​ | ​ | ​    | ​ | F-95 | ​ | ​ |

| ​                                                                                                                                                        
 Unaudited condensed balance sheets as of September 30, 2024 and December 31, 2023.                                                                       
 Unaudited condensed statements of operations for the nine months ended September 30, 2024 and2023                                                        | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | Page 
 ​    
 ​    | ​ 
 ​ | F-115 
 F-116 | ​ 
 ​ | ​ 
 ​ 
 ​ |
|:---------------------------------------------------------------------------------------------------------------------------------------------------------|:--|:--|:-----|:--|:------|:--|:--|
| Unaudited condensed statements of redeemable convertible preferred stock and stockholders’ deficit for the nine months ended September 30, 2024 and 2023 | ​ | ​ | ​    | ​ | F-117 | ​ | ​ |
| Unaudited condensed statements of cash flows for the nine months ended September 30, 2024 and2023                                                        | ​ | ​ | ​    | ​ | F-118 | ​ | ​ |
| Notes to unaudited condensed financial statements                                                                                                        | ​ | ​ | ​    | ​ | F-119 | ​ | ​ |

F-1

TABLE OF CONTENTS

CARA THERAPEUTICS, INC. CONDENSED CONSOLIDATED BALANCE SHEETS
(amounts in thousands, excluding share and per share data)
(unaudited)

| ​                                                                                                                                                                                                                                                                  
 Assets                                                                                                                                                                                                                                                             
 Current assets:                                                                                                                                                                                                                                                    | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | September 30,2024 
 ​                 
 ​                 | ​ 
 ​ |        ​ 
        ​ | ​ 
 ​ | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | December 31,2023 
 ​                
 ​                | ​ 
 ​ |        ​ 
        ​ | ​ 
 ​ | ​ 
 ​ 
 ​ |
|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|:--|:--|:------------------|:--|---------:|:--|:--|:--|:-----------------|:--|---------:|:--|:--|
| Cash and cash equivalents                                                                                                                                                                                                                                          |